Healthcare provider profile · identity verified

Won Suk Choi, MD

Family Practice · PLYMOUTH, MN · NPI 1114189289

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	391	117
Lisinopril	Lisinopril	341	103
Simvastatin	Simvastatin	291	82
Amlodipine Besylate	Amlodipine Besylate	287	85
Losartan Potassium	Losartan Potassium	232	74
Levothyroxine Sodium	Levothyroxine Sodium	218	58
Rosuvastatin Calcium	Rosuvastatin Calcium	216	71
Omeprazole	Omeprazole	161	46
Metformin Hcl	Metformin Hcl	151	50
Gabapentin	Gabapentin	148	46
Tamsulosin Hcl	Tamsulosin Hcl	146	49
Metformin Hcl Er	Metformin Hcl	120	36
Metoprolol Succinate	Metoprolol Succinate	118	37
Hydrochlorothiazide	Hydrochlorothiazide	116	39
Celecoxib	Celecoxib	106	28
Warfarin Sodium	Warfarin Sodium	100	27
Trazodone Hcl	Trazodone Hcl	98	29
Jardiance	Empagliflozin	95	27
Metoprolol Tartrate	Metoprolol Tartrate	94	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	14
Pantoprazole Sodium	Pantoprazole Sodium	88	30
Allopurinol	Allopurinol	82	26
Lorazepam	Lorazepam	81	13
Pravastatin Sodium	Pravastatin Sodium	73	23
Atenolol	Atenolol	64	21
Montelukast Sodium	Montelukast Sodium	63	20
Sertraline Hcl	Sertraline Hcl	58	17
Ozempic	Semaglutide	56	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Zolpidem Tartrate	Zolpidem Tartrate	55	11
Albuterol Sulfate Hfa	Albuterol Sulfate	53	24
Citalopram Hbr	Citalopram Hydrobromide	53	17
Tizanidine Hcl	Tizanidine Hcl	51	12
Eliquis	Apixaban	50	13
Furosemide	Furosemide	50	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	14
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Finasteride	Finasteride	40	13
Glipizide Er	Glipizide	40	11
Carvedilol	Carvedilol	39	13
Terazosin Hcl	Terazosin Hcl	37	11
Xarelto	Rivaroxaban	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	24
Alendronate Sodium	Alendronate Sodium	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Lovastatin	Lovastatin	35	11
Sucralfate	Sucralfate	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Clonazepam	Clonazepam	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Cefdinir	Cefdinir	28	24
Cephalexin	Cephalexin	28	19
Chlorthalidone	Chlorthalidone	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Prednisone	Prednisone	28	18
Famotidine	Famotidine	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Fenofibrate	Fenofibrate,micronized	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Methadone Hcl	Methadone Hcl	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	15
Fluticasone Propionate	Fluticasone Propionate	21	12
Spironolactone	Spironolactone	21	suppressed
Topiramate	Topiramate	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Metronidazole	Metronidazole	16	11
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Ativan	Lorazepam	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Glipizide	Glipizide	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Belsomra	Suvorexant	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error